Pharmaceuticals

Nasus Pharma

Nasus Pharma released FY2025 Q3 earnings on March 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD 0 (forecast USD -0.14)

Nasus Pharma released FY2025 earnings on March 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.731 (forecast USD -0.685)

Nasus Pharma released FY2025 9 Months Earnings on March 25, 2026 (EST) with actual revenue USD 0 and EPS USD -0.17

Nasus Pharma released FY2025 Q4 earnings on March 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD 0 (forecast USD -0.38)

Nasus Pharma Ltd. to Attend Three Investor Conferences

Nasus Pharma released FY2025 Q2 earnings on December 29 (EST), actual revenue USD 0, actual EPS USD -0.085

Nasus Pharma released FY2025 Q1 earnings on December 29, 2025, EST with actual revenue of USD 0 and EPS of USD -0.085

Nasus Pharma released FY2025 Semi-Annual earnings on December 29 (EST), actual revenue USD 0, actual EPS USD -0.17

Nasus Pharma Expands Collaboration with AptarGroup to Enhance NS002 Nasal Adrenaline Program Development

Nasus Pharma released FY2024 Annual Earnings on March 21 (EST), Actual Revenue: USD 0, Actual EPS: USD -0.2179

Nasus Pharma released FY2023 Q4 earnings on March 21, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0607

Nasus Pharma released FY2024 Q4 earnings on March 21, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0461

Nasus Pharma released FY2024 Q3 earnings on March 21 (EST), actual revenue USD 0, actual EPS USD -0.0461

Nasus Pharma released FY2024 9 Months Earnings on March 21 (EST), actual revenue USD 0, actual EPS USD -0.174

Nasus Pharma released FY2023 9 Months earnings on March 21 (EST), actual revenue USD 0, actual EPS USD -0.1546

Nasus Pharma released FY2023 Q3 earnings on March 21 (EST), actual revenue USD 0, actual EPS USD -0.0607

Nasus Pharma released FY2023 Annual Earnings on March 21 (EST), actual revenue USD 0, actual EPS USD -0.2

Nasus Pharma released FY2024 Q1 earnings on December 31, 2024, EST with actual revenue of USD 0 and actual EPS of USD -0.0639

Nasus Pharma released FY2024 Semi-Annual Earnings on December 31 (EST), actual revenue USD 0, actual EPS USD -0.1279

Nasus Pharma released FY2023 Semi-Annual earnings on December 31, 2024 (EST), with actual revenue of USD 0 and EPS of USD -0.0939

Fusemachines

Erayak Power Solution

Smart Powerr

Sky Quarry

Cue BioPharma

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

ZeZentalis Pharma

XCF Global

Rackspace Tech

U Power

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Nasus Pharma(NSRX.US)

Nasus Pharma Stock Performance Chart